TY - JOUR
T1 - Investigating Dopamine Replacement–Associated Fluctuations in Cognition and Mood in Cognitively Unimpaired Parkinson's Disease
AU - Mahajan, Abhimanyu
AU - Morrow, Christopher B.
AU - Seemiller, Joseph
AU - Mills, Kelly A.
AU - Pontone, Gregory M.
N1 - Publisher Copyright:
© 2025 The Author(s). Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
PY - 2025/10
Y1 - 2025/10
N2 - Background: Non-motor fluctuations, characterized by variability in mood and cognition, are prevalent in advanced Parkinson's disease (PD), but less is known about these fluctuations in early PD. Objective: The objective was to characterize fluctuations in cognition and mood in early PD without cognitive impairment. Methods: Individuals with PD but without cognitive impairment were evaluated “on” and “off” dopaminergic medications for minimal clinically important differences (MCID) in depression, anxiety, and cognition. Multivariable logistic regression evaluated factors associated with medication-related fluctuations in anxiety, depression, and cognition. Results: Clinically meaningful fluctuations in anxiety were associated with dysautonomia (OR [odds ratio] 7.5) and female sex (OR 3.9). Fluctuations in Symbol Digit Modalities Test (SDMT), a measure of processing speed and executive function, were associated with dysautonomia (OR 2.82). Such an association was not found with depression or Stroop test. Conclusions: Dysautonomia may influence fluctuations in anxiety and some aspects of cognition in cognitively unimpaired PD.
AB - Background: Non-motor fluctuations, characterized by variability in mood and cognition, are prevalent in advanced Parkinson's disease (PD), but less is known about these fluctuations in early PD. Objective: The objective was to characterize fluctuations in cognition and mood in early PD without cognitive impairment. Methods: Individuals with PD but without cognitive impairment were evaluated “on” and “off” dopaminergic medications for minimal clinically important differences (MCID) in depression, anxiety, and cognition. Multivariable logistic regression evaluated factors associated with medication-related fluctuations in anxiety, depression, and cognition. Results: Clinically meaningful fluctuations in anxiety were associated with dysautonomia (OR [odds ratio] 7.5) and female sex (OR 3.9). Fluctuations in Symbol Digit Modalities Test (SDMT), a measure of processing speed and executive function, were associated with dysautonomia (OR 2.82). Such an association was not found with depression or Stroop test. Conclusions: Dysautonomia may influence fluctuations in anxiety and some aspects of cognition in cognitively unimpaired PD.
UR - https://www.scopus.com/pages/publications/105003495536
UR - https://www.scopus.com/inward/citedby.url?scp=105003495536&partnerID=8YFLogxK
U2 - 10.1002/mdc3.70100
DO - 10.1002/mdc3.70100
M3 - Article
AN - SCOPUS:105003495536
SN - 2330-1619
VL - 12
SP - 1609
EP - 1614
JO - Movement Disorders Clinical Practice
JF - Movement Disorders Clinical Practice
IS - 10
ER -